Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
McMaster University
$120,000.00
Using influenza vaccines to provide heterologous protection through trained innate immunity
EF 2025-26
Résumé
Vaccines are one of the most powerful tools we have to protect people from infectious diseases. Traditionally, vaccines are designed to train the adaptive immune system to recognize and fight a specific virus or bacterium. However, recent discoveries show that the first line of defense in our immune system, the innate immune system, can also develop a type of "memory." This process called trained innate immunity, allows the body to respond more strongly to a wide range of infections, not just the one the vaccine was originally designed for. Some vaccines, such as the tuberculosis vaccine (BCG), have already been shown to reduce illness and death from unrelated respiratory infections, demonstrating this broad protective effect. Seasonal influenza vaccines are used worldwide every year, but it is not yet well understood whether they can also trigger trained innate immunity and provide this kind of extra, non-specific protection. Because flu vaccines are given to millions of people annually and come in different forms, understanding their broader effects could help us improve protection against new or unexpected infectious diseases. This research will test how different types of influenza vaccines influence trained innate immunity. Using mouse models, we will; 1) Study how flu vaccines change the activity and behavior of key immune cells, 2) Test whether these changes improve protection against unrelated infections, such as COVID-19 or pneumonia, and 3) Identify which immune cells and molecular signals are responsible for this extra protection. By uncovering how flu vaccines can strengthen broad immune defenses, this project could guide the design of next-generation vaccines that not only protect against their target disease but also provide rapid, wide-ranging protection during future outbreaks and pandemics. Additionally, the flu platform with the best heterologous protection can be utilized during pandemics when pathogen-specific vaccines are not readily available.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559307
Name
Amaral Kyle
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Using influenza vaccines to provide heterologous protection through trained innate immunity
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Flow Cytometry; Heterologous Immunity; Immunometabolism; Influenza Vaccines; Innate Immune Cells; Murine Models; Pandemic Preparedness; Public Health; Trained Innate Immunity; Transcriptomics
Abstract
Vaccines are one of the most powerful tools we have to protect people from infectious diseases. Traditionally, vaccines are designed to train the adaptive immune system to recognize and fight a specific virus or bacterium. However, recent discoveries show that the first line of defense in our immune system, the innate immune system, can also develop a type of "memory." This process called trained innate immunity, allows the body to respond more strongly to a wide range of infections, not just the one the vaccine was originally designed for. Some vaccines, such as the tuberculosis vaccine (BCG), have already been shown to reduce illness and death from unrelated respiratory infections, demonstrating this broad protective effect. Seasonal influenza vaccines are used worldwide every year, but it is not yet well understood whether they can also trigger trained innate immunity and provide this kind of extra, non-specific protection. Because flu vaccines are given to millions of people annually and come in different forms, understanding their broader effects could help us improve protection against new or unexpected infectious diseases. This research will test how different types of influenza vaccines influence trained innate immunity. Using mouse models, we will; 1) Study how flu vaccines change the activity and behavior of key immune cells, 2) Test whether these changes improve protection against unrelated infections, such as COVID-19 or pneumonia, and 3) Identify which immune cells and molecular signals are responsible for this extra protection. By uncovering how flu vaccines can strengthen broad immune defenses, this project could guide the design of next-generation vaccines that not only protect against their target disease but also provide rapid, wide-ranging protection during future outbreaks and pandemics. Additionally, the flu platform with the best heterologous protection can be utilized during pandemics when pathogen-specific vaccines are not readily available.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Amaral, Kyle
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~